Waters Corporation

Equities

WAT

US9418481035

Advanced Medical Equipment & Technology

Market Closed - Nyse 21:00:02 15/07/2024 BST 5-day change 1st Jan Change
302.9 USD +0.18% Intraday chart for Waters Corporation +6.08% -7.99%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
TD Cowen Adjusts Price Target on Waters to $325 From $358, Maintains Hold Rating MT
Evercore ISI Adjusts Price Target on Waters to $300 From $320, Maintains In-Line Rating MT
Waters Corporation(NYSE:WAT) added to Russell Midcap Value Index CI
Waters Corporation(NYSE:WAT) added to Russell 3000 Value Index CI
Waters Corporation(NYSE:WAT) added to Russell 1000 Value-Defensive Index CI
Waters Corporation(NYSE:WAT) added to Russell 1000 Value Index CI
Waters Corporation(NYSE:WAT) added to Russell 3000E Value Index CI
Barclays Adjusts Price Target on Waters to $275 From $295 MT
Transcript : Waters Corporation Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 09:30 AM
Waters Insider Bought Shares Worth $332,900, According to a Recent SEC Filing MT
Deutsche Bank Adjusts Waters Price Target to $330 From $304 MT
Waters Corp Insider Sold Shares Worth $1,446,560, According to a Recent SEC Filing MT
Bernstein Adjusts Price Target on Waters to $307 From $304 MT
JPMorgan Adjusts Price Target on Waters to $315 From $300 MT
TD Cowen Adjusts Price Target on Waters to $358 From $350 MT
Stifel Nicolaus Adjusts Waters Price Target to $332 From $330 MT
Baird Adjusts Waters Price Target to $312 From $319 MT
Bio-Rad Laboratories reiterates 2024 revenue growth outlook; shares slip RE
Barclays Lowers Waters' Price Target to $295 From $300 MT
Evercore IS Adjusts Waters' Price Target to $320 From $340, Keeps In Line Rating MT
Waters Seeks M&A Opportunities CI
Transcript : Waters Corporation, Q1 2024 Earnings Call, May 07, 2024
Waters' Q1 Non-GAAP Earnings, Net Sales Decline; Q2 Outlook Issued MT
Earnings Flash (WAT) WATERS CORPORATION Reports Q1 Revenue $636.8M MT
Earnings Flash (WAT) WATERS CORPORATION Reports Q1 Adjusted EPS $2.21 MT
Chart Waters Corporation
More charts
Waters Corporation specializes in the conception, the manufacturing and the marketing of analytical instruments. Net sales break down by activity as follows: - sale of instruments and analytical systems (63.6%): chromatographic analysis instruments (59.5% of net sales; instruments high performance liquid chromatography and mass spectrometry), chemistry consumables (28.9%; including columns chemical separation) and thermal analysis, rheometry and calorimetry instruments (11.6%) ; - services (36.7%): support services, training, etc. Net sales are distributed by market between pharmaceutical (58.6%), industrial (29.9%), academic institutions and governmental agencies (11.4%). Net sales are distributed geographically as follows: the United States (28.7%), Americas (5.1%), China (17.1%), Japan (7.6%), Asia (13.3%) and Europe (28.2%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
302.9 USD
Average target price
320.8 USD
Spread / Average Target
+5.91%
Consensus
  1. Stock Market
  2. Equities
  3. WAT Stock
  4. News Waters Corporation
  5. TD Cowen Adjusts Price Target on Waters to $325 From $358, Maintains Hold Rating